Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials
Related Posts
Roberts AM, Jeong C, Chou P, Ma EJ, Katz A, Yan MJ, Johnsen N, Nong Y, Armstrong AW. Association between out-of-pocket costs and treatment patterns[...]
Issa T, Klomhaus AM, Kasakevich C, Pickford J, Goh C. Central centrifugal cicatricial alopecia is associated with longer time to diagnosis among scarring alopecias. JAAD[...]
Jeong C, Roberts A, Hur M, Chou P, Katz A, Ma E, Yan MJ, Johnsen N, Nong Y, Armstrong AW. Quantifying Treatment Burden in Hidradenitis[...]